Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Schernthaner, G; Drexel, H; Rosenkranz, AR; Schernthaner, GH; Watschinger, B; Ausrian Diabetes Association.
Antihypertensive therapy in diabetes mellitus - 2012 guidelines of the Austrian Diabetes Association].
Wien Klin Wochenschr. 2012; 124 Suppl 2(3):23-27
Doi: 10.1007/s00508-012-0270-6
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Rosenkranz Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Blood pressure lowering is one of the most important interventions for reducing the vascular complications and mortality in patients with diabetes mellitus. Recent studies indicate that the optimal blood pressure level might be in the range between 130-135 mmHg systolic and 80 mmHg diastolic. Lower blood pressure levels (e.g. 120/80 mmHg) can further reduce the risk for stroke and diabetic nephropathy, but are associated with increased cardiovascular mortality. In particular very low blood pressure levels (< 120 mmHg) should be avoided in patients with coronary heart disease or peripheral arterial disease. Most patients with diabetes mellitus need antihypertensive combination therapies, whereby ACE-inhibitors or Angiotensin-II receptor antagonists should be first line drugs.
- Find related publications in this database (using NLM MeSH Indexing)
- Antihypertensive Agents - administration & dosage
- Antihypertensive Agents -
- Diabetes Complications - drug therapy
- Humans -
- Hypertension - drug therapy
- Practice Guidelines as Topic -
- Find related publications in this database (Keywords)
- Diabetes mellitus
- Blood pressure lowering
- Antihypertensive therapy
- Myocardial infarction
- Stroke
- Diabetic nephropathy